UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: a Pilot Study

Phase 4

Not yet recruiting

Conditions: Postpartum Contraception
Depot Medroxyprogesterone Acetate
Lactation
DMPA

Interventions: Drug: Depo Medroxyprogesterone acetate

First Posted Date: 2025-02-10

Last Posted Date: 2025-02-11

Lead Sponsor: University of California, San Diego

Target Recruit Count: 40

Registration Number: NCT06816901

Locations: 🇳🇵
Provincial Hospital Janakpur of Dhanusha district, Janakpur, Dhanusha district, Nepal

Psilocybin-Assisted Therapy for Physician Well-Being and Burnout

Phase 1

Not yet recruiting

Conditions: Burnout, Healthcare Workers
Burnout

Interventions: Drug: Psilocybin, [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate

First Posted Date: 2025-02-07

Last Posted Date: 2025-02-07

Lead Sponsor: University of California, San Diego

Target Recruit Count: 10

Registration Number: NCT06814522

Cemiplimab Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Phase 2

Not yet recruiting

Conditions: Pancreatic Ductal Adenocarcinoma (mPDAC)

Interventions: Drug: Cemiplimab Plus Gemcitabine

First Posted Date: 2025-01-24

Last Posted Date: 2025-01-24

Lead Sponsor: University of California, San Diego

Target Recruit Count: 40

Registration Number: NCT06790602

Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty

Phase 4

Not yet recruiting

Conditions: Acute Postoperative Pain
Surgery

Interventions: Device: continuous peripheral nerve block with OnQ pump
Drug: single injection nerve block

First Posted Date: 2025-01-20

Last Posted Date: 2025-01-20

Lead Sponsor: University of California, San Diego

Target Recruit Count: 40

Registration Number: NCT06784882

TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus

Phase 2

Recruiting

Conditions: Immunotherapy-related Pruritus

Interventions: Drug: Tricalm Hydrogel
Drug: Triamcinolone acetonide 0.1% cream

First Posted Date: 2024-12-27

Last Posted Date: 2025-02-11

Lead Sponsor: University of California, San Diego

Target Recruit Count: 28

Registration Number: NCT06748404

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

Dose-Optimized and Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression

Not Applicable

Recruiting

Conditions: Treatment Resistant Depression
Major Depressive Disorder

First Posted Date: 2024-12-12

Last Posted Date: 2024-12-12

Lead Sponsor: University of California, San Diego

Target Recruit Count: 75

Registration Number: NCT06730841

Locations: 🇺🇸
UCSD Interventional Psychiatry, San Diego, California, United States

Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes

Not Applicable

Not yet recruiting

Conditions: Type 1 Diabetes Mellitus

First Posted Date: 2024-12-10

Last Posted Date: 2024-12-10

Lead Sponsor: University of California, San Diego

Target Recruit Count: 20

Registration Number: NCT06727071

Locations: 🇺🇸
University of California, San Diego - ACTRI, La Jolla, California, United States

The RELIEF™ Ureteral Stent Randomized Controlled Trial

Not Applicable

Not yet recruiting

Conditions: Kidney Stone

First Posted Date: 2024-12-06

Last Posted Date: 2024-12-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 50

Registration Number: NCT06720740

Thulium Fiber Laser (TFL) vs Thulio Pulsed Thulium:YAG (p-Tm:YAG)

Not Applicable

Recruiting

Conditions: Kidney Stones
Nephrolithiasis

First Posted Date: 2024-12-06

Last Posted Date: 2024-12-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 50

Registration Number: NCT06721975

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

Elranatamab in Relapsed/Refractory Multiple Myeloma

Phase 2

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Elranatamab

First Posted Date: 2024-12-02

Last Posted Date: 2025-02-11

Lead Sponsor: University of California, San Diego

Target Recruit Count: 33

Registration Number: NCT06711705

Locations: 🇺🇸
University of California San Diego, La Jolla, California, United States

Home Terms & Conditions Privacy Policy